• Primary Endpoint Met in Corvia Medical's Reduce LAP-HF I Study biospace
    December 26, 2017
    Privately-held Corvia Medical said its investigational transcatheter structural heart device to treat heart failure has demonstrated success in reducing exercise pulmonary capillary wedge pressure in trial patients.
PharmaSources Customer Service